Related Experiment Video
Updated: Jan 6, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Engineered Stem Cells Provide Cancer-Killing iNKT Cells
Mallory Paynich Murray1, Mitchell Kronenberg1
1La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Abstract:
Invariant natural killer T (iNKT) cells have been tested for their potential use in cancer immune therapy, but their low frequency has limited their use. In this issue, Zhu and colleagues propose to overcome this by engineering hematopoietic stem cells (HSCs) to provide a continual source of iNKT cells. (Zhu et al., 2019).
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
iPS Cell Differentiation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells

